Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 1;24(3):669-676.
doi: 10.1093/jamia/ocw160.

Cost and economic benefit of clinical decision support systems for cardiovascular disease prevention: a community guide systematic review

Verughese Jacob  1 , Anilkrishna B Thota  1 , Sajal K Chattopadhyay  1 , Gibril J Njie  1 , Krista K Proia  1 , David P Hopkins  1 , Murray N Ross  2 , Nicolaas P Pronk  3 , John M Clymer  4
Affiliations

Cost and economic benefit of clinical decision support systems for cardiovascular disease prevention: a community guide systematic review

Verughese Jacob et al. J Am Med Inform Assoc. .

Abstract

Objective: This review evaluates costs and benefits associated with acquiring, implementing, and operating clinical decision support systems (CDSSs) to prevent cardiovascular disease (CVD).

Materials and methods: Methods developed for the Community Guide were used to review CDSS literature covering the period from January 1976 to October 2015. Twenty-one studies were identified for inclusion.

Results: It was difficult to draw a meaningful estimate for the cost of acquiring and operating CDSSs to prevent CVD from the available studies ( n = 12) due to considerable heterogeneity. Several studies ( n = 11) indicated that health care costs were averted by using CDSSs but many were partial assessments that did not consider all components of health care. Four cost-benefit studies reached conflicting conclusions about the net benefit of CDSSs based on incomplete assessments of costs and benefits. Three cost-utility studies indicated inconsistent conclusions regarding cost-effectiveness based on a conservative $50,000 threshold.

Discussion: Intervention costs were not negligible, but specific estimates were not derived because of the heterogeneity of implementation and reporting metrics. Expected economic benefits from averted health care cost could not be determined with confidence because many studies did not fully account for all components of health care.

Conclusion: We were unable to conclude whether CDSSs for CVD prevention is either cost-beneficial or cost-effective. Several evidence gaps are identified, most prominently a lack of information about major drivers of cost and benefit, a lack of standard metrics for the cost of CDSSs, and not allowing for useful life of a CDSS that generally extends beyond one accounting period.

Keywords: Decision support systems; clinical; economics; economics; medical.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Search process
See this image and copyright information in PMC

References

    1. Mozaffarian D, Benjamin EJ, Go AS et al. . Executive summary: heart disease and stroke statistics 2016 update—a report from the American Heart Association. Circulation. 2016;133(4):447–54. - PubMed
    1. Community Preventive Services Task Force. Clinical decision support systems recommended to prevent cardiovascular disease. Am. J. Prev. Med. 2015;49(5):796–99. - PubMed
    1. Njie GJ, Proia KK, Thota AB et al. . Clinical decision support systems and prevention: a Community Guide cardiovascular disease systematic review. Am. J. Prev. Med. 2015;49(5):784–95. - PMC - PubMed
    1. Guide to Community Preventive Services. Economic Reviews. 2014. Available at: https://www.thecommunityguide.org/about/economic-reviews. Accessed September 14, 2016.
    1. Bright TJ, Wong A, Dhurjati R et al. . Effect of clinical decision-support systems: a systematic review. Ann. Intern. Med. 2012;157(1):29–43. - PubMed

Publication types

MeSH terms

LinkOut - more resources